Otonomy Presents AuriPro Phase 3 Results at American Society of Pediatric Otolaryngology Conference
April 27, 2015 at 07:32 AM EDT
Otonomy, Inc. (Nasdaq: OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative ...